A Novel Approach to Contrast-Enhanced Breast Magnetic Resonance Imaging for Screening: High-Resolution Ultrafast Dynamic Imaging

ObjectivesThe use of breast magnetic resonance imaging (MRI) as screening tool has been stalled by high examination costs. Scan protocols have lengthened to optimize specificity. Modern view-sharing sequences now enable ultrafast dynamic whole-breast MRI, allowing much shorter and more cost-effective procedures. This study evaluates whether dynamic information from ultrafast breast MRI can be used to replace standard dynamic information to preserve accuracy. Materials and MethodsWe interleaved 20 ultrafast time-resolved angiography with stochastic trajectory (TWIST) acquisitions (0.9 × 1 × 2.5 mm, temporal resolution, 4.3 seconds) during contrast inflow in a regular high-resolution dynamic MRI protocol. A total of 160 consecutive patients with 199 enhancing abnormalities (95 benign and 104 malignant) were included. The maximum slope of the relative enhancement versus time curve (MS) obtained from the TWIST and curve type obtained from the regular dynamic sequence as defined in the breast imaging reporting and data system (BIRADS) lexicon were recorded. Diagnostic performance was compared using receiver operating characteristic analysis. ResultsAll lesions were visible on both the TWIST and standard series. Maximum slope allows discrimination between benign and malignant disease with high accuracy (area under the curve, 0.829). Types of MS were defined in analogy to BIRADS curve types: MS type 3 implies a high risk of malignancy (MS >13.3%/s; specificity, 85%), MS type 2 yields intermediate risk (MS <13.3%/s and >6.4%/s), and MS type 1 implies a low risk (MS <6.4%/s; sensitivity, 90%). This simplification provides a much higher accuracy than the much lengthier BIRADS curve type analysis does (area under the curve, 0.812 vs 0.692; P = 0.0061). ConclusionsUltrafast dynamic breast MRI allows detection of breast lesions and classification with high accuracy using MS. This allows substantial shortening of scan protocols and hence reduces imaging costs, which is beneficial especially for screening.

[1]  Karl-Heinz Herrmann,et al.  Resolving arterial phase and temporal enhancement characteristics in DCE MRM at high spatial resolution with TWIST acquisition , 2011, Journal of magnetic resonance imaging : JMRI.

[2]  C. Flowers,et al.  Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population , 2009, BMC health services research.

[3]  Yuan Le,et al.  Development and evaluation of TWIST Dixon for dynamic contrast‐enhanced (DCE) MRI with improved acquisition efficiency and fat suppression , 2012, Journal of magnetic resonance imaging : JMRI.

[4]  L J van Erning,et al.  MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. , 1994, Radiology.

[5]  Wei Huang,et al.  A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings. , 2012, Magnetic resonance imaging.

[6]  R. Mann,et al.  Ductal carcinoma in situ and breast MRI , 2007, The Lancet.

[7]  G Lutterbey,et al.  Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. , 1997, Radiology.

[8]  C. Kuhl Breast MR imaging at 3T. , 2007, Magnetic resonance imaging clinics of North America.

[9]  J. Klijn,et al.  Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer , 2006, Breast Cancer Research and Treatment.

[10]  H. Niendorf,et al.  Tolerance data of Gd-DTPA: a review. , 1991, European journal of radiology.

[11]  B. Hamm,et al.  Pharmacokinetic Approach for Dynamic Breast MRI to Indicate Signal Intensity Time Curves of Benign and Malignant Lesions by Using the Tumor Flow Residence Time , 2013, Investigative radiology.

[12]  Nico Karssemeijer,et al.  Automated Characterization of Breast Lesions Imaged With an Ultrafast DCE-MR Protocol , 2014, IEEE Transactions on Medical Imaging.

[13]  H. Bieling,et al.  Accelerated breast MRI for breast cancer screening. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Hallquist,et al.  Anticipatory psychological distress in women scheduled for diagnostic and curative breast cancer surgery. , 2008, International Journal of Behavioral Medicine.

[15]  Usha Sinha,et al.  In vivo diffusion‐weighted MRI of the breast: Potential for lesion characterization , 2002, Journal of magnetic resonance imaging : JMRI.

[16]  Henkjan Huisman,et al.  Comparison of enhancement characteristics between invasive lobular carcinoma and invasive ductal carcinoma , 2011, Journal of magnetic resonance imaging : JMRI.

[17]  Wolfgang Bogner,et al.  A Combined High Temporal and High Spatial Resolution 3 Tesla MR Imaging Protocol for the Assessment of Breast Lesions: Initial Results , 2009, Investigative radiology.

[18]  Qingli Zhu,et al.  Differentiation of Benign and Malignant Sub‐1‐cm Breast Lesions Using Contrast‐Enhanced Sonography , 2015, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[19]  Katarzyna J Macura,et al.  Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. , 2010, Radiology.

[20]  J. Austoker,et al.  The psychological impact of mammographic screening. A systematic review , 2005, Psycho-oncology.

[21]  A R Padhani,et al.  Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer , 2006, British Journal of Cancer.

[22]  Wendy B DeMartini,et al.  BI‐RADS MRI Enhancement Characteristics of Ductal Carcinoma In Situ , 2007, The breast journal.

[23]  Daniel B Kopans,et al.  Physiologic Changes in Breast Magnetic Resonance Imaging during the Menstrual Cycle: Perfusion Imaging, Signal Enhancement, and Influence of the T1 Relaxation Time of Breast Tissue , 2005, The breast journal.

[24]  C. Geppert,et al.  Application of time‐resolved angiography with stochastic trajectories (twist)‐dixon in dynamic contrast‐enhanced (dce) breast mri , 2013, Journal of magnetic resonance imaging : JMRI.

[25]  Peter Reimer,et al.  Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines , 2013, European Radiology.

[26]  H. D. de Koning,et al.  Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging. , 2013, Journal of the National Cancer Institute.

[27]  G. Oster,et al.  Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. , 2009, Journal of the American College of Radiology : JACR.

[28]  Roberto Orecchia,et al.  Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. , 2010, European journal of cancer.

[29]  F. Sardanelli,et al.  Breast MRI using a high-relaxivity contrast agent: an overview. , 2011, AJR. American journal of roentgenology.

[30]  Jeffrey D Blume,et al.  Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. , 2010, Radiology.

[31]  Maximilian Reiser,et al.  Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Karel G M Moons,et al.  Meta-analysis of MR imaging in the diagnosis of breast lesions. , 2008, Radiology.

[33]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[34]  W. J. Lorenz,et al.  Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography , 1995, Magnetic resonance in medicine.

[35]  P. Salkovskis,et al.  Claustrophobia in MRI: the role of cognitions. , 2008, Magnetic resonance imaging.

[36]  Wei Huang,et al.  Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging. , 2011, Radiology.

[37]  W. Kaiser,et al.  The Necrosis Sign in Magnetic Resonance‐Mammography: Diagnostic Accuracy in 1,084 Histologically Verified Breast Lesions , 2010, The breast journal.

[38]  Simone Schrading,et al.  MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study , 2007, The Lancet.

[39]  W. Kaiser,et al.  Nonmass Lesions in Magnetic Resonance Imaging of the Breast: Additional T2-Weighted Images Improve Diagnostic Accuracy , 2011, Journal of computer assisted tomography.

[40]  P S Tofts,et al.  Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.

[41]  Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers , 2013, BMC Cancer.

[42]  C. Balleyguier,et al.  Computed-aided diagnosis (CAD) in the detection of breast cancer. , 2013, European journal of radiology.

[43]  G P Liney,et al.  Differentiation of benign and malignant sub-1 cm breast lesions using dynamic contrast enhanced MRI. , 2004, Breast.

[44]  C. Catalano,et al.  Effect of Preoperative Breast Magnetic Resonance Imaging on Surgical Decision Making and Cancer Recurrence Rates , 2012, Investigative radiology.

[45]  C. Kuhl,et al.  Mammographic, US, and MR imaging phenotypes of familial breast cancer. , 2008, Radiology.

[46]  C. Boetes,et al.  Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions , 2008, European Radiology.

[47]  Wendy B DeMartini,et al.  BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement. , 2009, AJR. American journal of roentgenology.

[48]  W E Reddick,et al.  Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharmacokinetic MRI. , 2000, Advanced drug delivery reviews.

[49]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[50]  M. Knopp,et al.  Dynamic contrast‐enhanced MRI using Gd‐DTPA: Interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors , 2001, Magnetic resonance in medicine.

[51]  Ning-Yu An,et al.  Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[52]  C. Boetes,et al.  Breast MRI: guidelines from the European Society of Breast Imaging , 2008, European Radiology.

[53]  N. Hylton,et al.  Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. , 2006, Radiology.